Piper Sandler analyst Yasmeen Rahimi initiated coverage of Immunovant with an Overweight rating and $28 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IMVT:
Piper Sandler analyst Yasmeen Rahimi initiated coverage of Immunovant with an Overweight rating and $28 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IMVT: